Apollomics, Inc. (APLM) vs Tenax Therapeutics, Inc. (TENX)
A side-by-side comparison of Apollomics, Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TENX
Tenax Therapeutics, Inc.
$1.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — APLM vs TENX
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)TENX -99.9% (-75.1%/yr)APLM compounded faster over this window
Log scale — wide-divergence pair
APLM TENX
APLM vs TENX: by the numbers
- •TENX is the larger company ($51M vs $49M market cap).
- •Both run net losses; TENX's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | APLM | TENX |
|---|---|---|
| P/B ratio | N/A | 0.45 |
Profitability
| Metric | APLM | TENX |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | 0.00% |
| ROE | N/A | -57.10% |
| ROIC | -2441.49% | -60.40% |
Growth (annualized)
| Metric | APLM | TENX |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | -76.80% |
Go deeper
Dig into the metrics
Apollomics ROETenax Therapeutics ROEApollomics operating marginTenax Therapeutics operating marginApollomics revenue growthTenax Therapeutics revenue growthApollomics free cash flowTenax Therapeutics free cash flow
Apollomics & Tenax Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.